BlackRock Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

BlackRock Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3.14M	Sell	56,986 -1,844	-3%	-$101K	﹤0.01%	1315
2016 Q3	$3.32M	Buy	58,830 +15,970	+37%	+$783K	﹤0.01%	1273
2016 Q2	$1.79M	Buy	42,860 +5,486	+15%	+$253K	﹤0.01%	1479
2016 Q1	$1.6M	Buy	37,374 +26,716	+251%	+$1.13M	﹤0.01%	1532
2015 Q4	$482K	Sell	10,658 -100,574	-90%	-$4.23M	﹤0.01%	2089
2015 Q3	$4.32M	Sell	111,232 -91,963	-45%	-$3.68M	﹤0.01%	1137
2015 Q2	$7.38M	Buy	203,195 +81,998	+68%	+$2.59M	0.01%	854
2015 Q1	$3.5M	Buy	121,197 +110,005	+983%	+$3.07M	﹤0.01%	1057
2014 Q4	$271K	Buy	+11,192	New	+$252K	﹤0.01%	2432

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

BlackRock Advisors's PRAH Position: Q4 2016 in Review

BlackRock Advisors reduced its PRA Health Sciences, Inc. (PRAH) stake by 3.1% in Q4 2016, selling an estimated $101K and leaving 56,986 shares worth $3.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1315.

BlackRock Advisors first reported a position in PRAH in Q4 2014 and has held it in 9 quarters since. The position peaked at $7.38M in Q2 2015. 188 funds tracked by Wall St. Rank hold PRAH as of Q4 2016.

BlackRock Advisors held 56,986 shares of PRA Health Sciences, Inc. worth $3.14M as of Q4 2016.
BlackRock Advisors sold 1,844 PRA Health Sciences, Inc. shares in Q4 2016, an estimated $101K.
PRA Health Sciences, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1315 holding.
BlackRock Advisors first reported a position in PRA Health Sciences, Inc. in Q4 2014 and has held it in 9 quarters since.
BlackRock Advisors's PRA Health Sciences, Inc. position peaked at $7.38M in Q2 2015.
188 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.